Stocktoria
GUIDED THERAPEUTICS INC GTHP
GUIDED THERAPEUTICS INC (GTHP) earns a Piotroski F-score of 3/9 (weak financial health). It does not currently pay a dividend. FY2025 revenue was $767,000 at a -416.7% net margin.
Quality score trend · recomputed for each fiscal year
Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.
How it ranks in Manufacturing · percentile among 2036 companies
Percentile vs other Manufacturing companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 3/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Sector peers · similar-size Manufacturing companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| GTHP | GUIDED THERAPEUTICS INC | 3/9 | — | — | — |
| ITOC | iTonic Holdings Ltd | 1/9 | 5.57 | — | — |
| POSC | POSITRON CORP | 2/9 | — | — | — |
| NXL | Nexalin Technology, Inc. | 4/9 | — | — | — |
| ENDV | ENDONOVO THERAPEUTICS, INC. | 3/9 | — | — | — |
| VANI | Vivani Medical, Inc. | 1/9 | -14.41 | — | — |
| HCIL | Hongchang International Co., Ltd | 2/9 | 2.23 | — | — |
About GUIDED THERAPEUTICS INC
Guided Therapeutics, Inc., a medical technology company, researches, develops, tests, manufactures, sells, and distributes medical devices in the United States and internationally. It offers LuViva, an advanced cervical scan non-invasive cervical cancer detection device that provides less invasive and painless alternative to conventional tests for identifying, screening, and detecting cervical cancers and precancers. The company was formerly known as SpectRx, Inc. and changed its name to Guided Therapeutics, Inc. in February 2008. Guided Therapeutics, Inc. was incorporated in 1992 and is headquartered in Peachtree Corners, Georgia.
FAQ
Is GTHP financially healthy?
GUIDED THERAPEUTICS INC's Piotroski F-score is 3/9 (8–9 is excellent, 0–3 weak).
Does GTHP pay a dividend?
No, GUIDED THERAPEUTICS INC does not currently pay a dividend.
How profitable is GTHP?
In FY2025, GUIDED THERAPEUTICS INC had a net margin of -416.7%.
Is GTHP a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on GUIDED THERAPEUTICS INC: a Piotroski F-score of 3/9. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.